Access cutting-edge invasive candidiasis treatment through this clinical trial at a research site in Denver. Study-provided care at no cost to qualified participants.
Access invasive candidiasis specialists in Denver at no cost
This study follows strict safety protocols and ethical guidelines
All study-related invasive candidiasis treatment provided free
This is a multicenter, randomized, double-blind study of two treatment regimens for invasive candidiasis included candidemia. Subjects will receive intravenous echinocandin followed by oral ibrexafungerp (SCY-078) vs intravenous echinocandin followed by oral fluconazole.
Sponsor: Scynexis, Inc.
Check if you qualify for this invasive candidiasis clinical trial in Denver, CO
If you're searching for invasive candidiasis treatment options in Denver, CO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Denver research site is actively enrolling participants for this clinical trial. You'll receive care from experienced invasive candidiasis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.